More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$2.88B
EPS
0.31
P/E ratio
--
Price to sales
6.31
Dividend yield
--
Beta
1.146054
Previous close
$11.94
Today's open
$11.94
Day's range
$11.43 - $11.94
52 week range
$9.58 - $19.98
show more
CEO
Shiven Ramji
Employees
1167
Headquarters
Petah Tikva,
Exchange
Nasdaq Global Select
Shares outstanding
251341060
Issue type
Common Stock
Technology
Software & IT Services
Cellebrite Announces Upcoming Investor Events in September
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.
PRNewsWire • Sep 4, 2026

Kaplan Fox Encourages Investors of Cellebrite DI Ltd. (CLBT) to Contact the Firm to Learn About Their Legal Rights
New York, New York--(Newsfile Corp. - September 4, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Newsfile Corp • Sep 4, 2026

Cellebrite Guardian Completes IRAP Assessment: Achieves PROTECTED Level for Australian Government Agencies
Independent assessment gives Australian law enforcement, defense and national security agencies a platform for collaborating and managing digital evidence in the cloud quickly and securely TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept.
PRNewsWire • Sep 2, 2026

Kaplan Fox is Investigating Cellebrite DI Ltd. (CLBT) for Potential Violations of the Federal Securities Laws
New York, New York--(Newsfile Corp. - September 2, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Newsfile Corp • Sep 2, 2026

Cellebrite: Mobile Forensics Leadership At A Compelling Valuation
Cellebrite offers ~90% recurring revenue and 117% net retention, anchored by mobile forensics leadership and new growth levers. Cellebrite is rated 'Buy' at ~$12, with a Fair Value estimate of $17.3, reflecting ~44% potential upside and a strong GARP profile. I see a narrow moat based on their leadership in mobile forensics, robust rule of X score, and cross-selling opportunities.
Seeking Alpha • Sep 2, 2026

Cellebrite Federal Solutions, Inc. (CFSI) Achieves U.S. Department of War's Advanced Cybersecurity Standard, Reinforcing Commitment to Secure Federal Operations
TYSONS CORNER, Va., Sept. 1, 2026 /PRNewswire/ -- Cellebrite (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced its subsidiary, Cellebrite Federal Solutions, Inc. (CFSI), achieved the advanced Cybersecurity Maturity Model Certification (CMMC) Level 2 accreditation, an independent assessment conducted by a Certified Third-Party Assessment Organization (C3PAO).
PRNewsWire • Sep 1, 2026

Kaplan Fox & Kilsheimer LLP is Investigating Cellebrite DI Ltd. (CLBT) for Possible Securities Law Violations
New York, New York--(Newsfile Corp. - August 31, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Newsfile Corp • Aug 31, 2026

Kaplan Fox Reminds Cellebrite DI Ltd. (CLBT) Investors of an Investigation into Potential Securities Law Violations
New York, New York--(Newsfile Corp. - August 28, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Newsfile Corp • Aug 28, 2026

Cellebrite Brings Battlefield Intelligence to the Armed Forces with Launch of Portable Tactical Extraction Kit (C-TEK)
Built around Cellebrite's industry-leading digital forensics capabilities, C-TEK helps forward-deployed teams quickly triage data from phones, SIM cards, drones and portable media to advance their missions TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 26, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
PRNewsWire • Aug 26, 2026

Kaplan Fox & Kilsheimer LLP Alerts Investors of Cellebrite DI Ltd. (CLBT) to an Investigation of Potential Securities Law Violations
New York, New York--(Newsfile Corp. - August 26, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ: CLBT).
Newsfile Corp • Aug 26, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Cellebrite DI Ltd. commission-free¹. Build wealth for the long term using automated trading and transfers.